spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  oral spray 

 HSMN NewsFeed - 23 Feb 2017
NovaDel Pharma Inc. Announces Dissolution of the Company
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2014
BMG PHARMA S.r.l - Milan, Italy - Has Granted Exclusive Distribution Rights to Samyang Biopharmaceutical Corporation for GelX(R) in the Territory of South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 30 Apr 2013
ECR Pharmaceuticals Announces Re-launch of Zolpimist(R) and DexPak(R), Divestiture of Hylase(R) and Orbivan(R) Brands, and Dr. Cameron Durrant Named President and CEO
Biopharmaceuticals Personnel Product Launch
 HSMN NewsFeed - 8 Apr 2013
NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist(TM) Technology and Certain Other Assets
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 20 Jan 2012
NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 9 Jun 2011
NovaDel Announces Changes in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2011
Zolpimist(TM) Oral Spray Launched in United States
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Feb 2011
ECR Pharmaceuticals Launches Zolpimist Oral Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jun 2010
NovaDel Pharma Inc. Announces Appointment of Craig Johnson as Senior Vice President, Chief Financial Officer and Secretary
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Jan 2010
NovaDel Appoints Steven B. Ratoff President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2008
BioAlliance Pharma SA appoints Pierre MORGON Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2008
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jun 2008
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 May 2008
NovaDel Announces European License Agreement for Ondansetron Oral Spray
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Jan 2008
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Aug 2007
NovaDel Announces Sublicense Agreement for Zensana(TM)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 1 Aug 2007
Hana Biosciences Licenses North American Commercial Rights for Zensana(TM) to Par Pharmaceutical in a $50 Million Deal
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Jul 2007
Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2007
Judgment Enters in Favor of Proveris Scientific Corporation in Patent Infringement Lawsuit against InnovaSystems, Inc.
Devices Drug Delivery Litigation
 HSMN NewsFeed - 23 Mar 2007
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2007
NovaDel Pharma Announces the Completion of Its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by Hana BioSciences
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2007
Hana Biosciences Reports Likely Delay in Launch of Zensana(TM)
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2006
NovaDel Appoints David Bergstrom as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2006
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
Biopharmaceuticals Drug Delivery FDA Cardiology
 HSMN NewsFeed - 28 Sep 2006
NovaDel Announces Positive Results from Pharmacokinetic Study of Improved Sumatriptan Oral Spray Formulation
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Jul 2006
NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 26 May 2006
FDA Accepts Submission for NitroMist as Complete Response
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
oral spray
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!